Mari Sargsyan

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Predictors of long-term complications after carotid endarterectomy

N N Burkov, A. R. Shabayev, R. Yu. Lider et al. · Pirogov Russian Journal of Surgery · 2019 · 18 citations

Progression of precerebral atherosclerosis and predictors of ischemic complications in cardiac patients

R S Tarasov, N N Burkov, A. I. Anufriyev et al. · Pirogov Russian Journal of Surgery · 2020 · 13 citations

COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study

Helena García-Llana, Nayara Panizo, Lorena Gandía et al. · Vaccines · 2022 · 10 citations · Full text

Psychological Co-morbidities, Psychoneuroimmunology, Hemodialysis Patients +15